BKV · BKV Corp · Insider Trading

The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2026.

The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $22.5900 to $22.7000, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2026.

The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $25.4900 to $25.9950, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2026.

The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2026.

The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2026.

The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $25.9200 to $26.3950, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The shares were acquired under the BKV Corporation Employee Stock Purchase Plan ("ESPP") in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). The reporting person is voluntarily reporting this transaction.

In accordance with the ESPP, these shares were purchased at a price equal to 85% of the lesser of (i) closing price of the Issuer's common stock on the first trading day of the offering period, January 1, 2026, or (ii) closing price of the Issuer's common stock on the last trading day of the offering period, June 30, 2026.

The shares were acquired under the BKV Corporation Employee Stock Purchase Plan ("ESPP") in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). The reporting person is voluntarily reporting this transaction.

In accordance with the ESPP, these shares were purchased at a price equal to 85% of the lesser of (i) closing price of the Issuer's common stock on the first trading day of the offering period, January 1, 2026, or (ii) closing price of the Issuer's common stock on the last trading day of the offering period, June 30, 2026.

The shares were acquired under the BKV Corporation Employee Stock Purchase Plan ("ESPP") in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). The reporting person is voluntarily reporting this transaction.

In accordance with the ESPP, these shares were purchased at a price equal to 85% of the lesser of (i) closing price of the Issuer's common stock on the first trading day of the offering period, January 1, 2026, or (ii) closing price of the Issuer's common stock on the last trading day of the offering period, June 30, 2026.

The shares were acquired under the BKV Corporation Employee Stock Purchase Plan ("ESPP") in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). The reporting person is voluntarily reporting this transaction.

In accordance with the ESPP, these shares were purchased at a price equal to 85% of the lesser of (i) closing price of the Issuer's common stock on the first trading day of the offering period, January 1, 2026, or (ii) closing price of the Issuer's common stock on the last trading day of the offering period, June 30, 2026.

The shares were acquired under the BKV Corporation Employee Stock Purchase Plan ("ESPP") in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). The reporting person is voluntarily reporting this transaction.

In accordance with the ESPP, these shares were purchased at a price equal to 85% of the lesser of (i) closing price of the Issuer's common stock on the first trading day of the offering period, January 1, 2026, or (ii) closing price of the Issuer's common stock on the last trading day of the offering period, June 30, 2026.

Represents restricted stock units granted to the reporting person under the Issuer's non-employee director compensation program that vest the day prior to Issuer's 2027 annual stockholder meeting. Each restricted stock unit represents a contingent right to receive one share of Common Stock.

Shares transferred to former spouse without consideration as part of a comprehensive division of marital assets. Following the transfer, the reporting person no longer has beneficial ownership of the transferred shares.

Represents restricted stock units granted to the reporting person under the Issuer's non-employee director compensation program that vest the day prior to Issuer's 2027 annual stockholder meeting. Each restricted stock unit represents a contingent right to receive one share of Common Stock.

Represents restricted stock units granted to the reporting person under the Issuer's non-employee director compensation program that vest the day prior to Issuer's 2027 annual stockholder meeting. Each restricted stock unit represents a contingent right to receive one share of Common Stock.

Represents restricted stock units granted to the reporting person under the Issuer's non-employee director compensation program that vest the day prior to Issuer's 2027 annual stockholder meeting. Each restricted stock unit represents a contingent right to receive one share of Common Stock.

Represents restricted stock units granted to the reporting person under the Issuer's non-employee director compensation program that vest the day prior to Issuer's 2027 annual stockholder meeting. Each restricted stock unit represents a contingent right to receive one share of Common Stock.

The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2025.

The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $26.31 to $27.12, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Represents shares of common stock, par value $0.01 per share ("Common Stock"), withheld to satisfy tax withholding obligations upon the vesting of restricted stock units previously reported on Form 4. This net settlement was approved by the board of directors of the Issuer pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended.

Represents restricted stock units granted to the reporting person under the BKV Corporation 2024 Equity and Incentive Compensation Plan that vest in three equal annual installments beginning on May 12, 2027. Each restricted stock unit represents a contingent right to receive one share of common stock, par value $0.01 per share.

The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2025.

The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $30.7100 to $31.2650, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Shares transferred to former spouse without consideration as part of a comprehensive division of marital assets. Following the transfer, the reporting person no longer has beneficial ownership of the transferred shares.

The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 3, 20225.

The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $29.46 to $29.8450, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 8, 2025.

The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.14, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Represents restricted stock units granted to the reporting person under the BKV Corporation 2024 Equity and Incentive Compensation Plan that vest in three equal annual installments beginning on March 10, 2027. Each restricted stock unit represents a contingent right to receive one share of common stock, par value $0.01 per share.

Represents restricted stock units granted to the reporting person under the BKV Corporation 2024 Equity and Incentive Compensation Plan that vest in three equal annual installments beginning on March 10, 2027. Each restricted stock unit represents a contingent right to receive one share of common stock, par value $0.01 per share.

Represents restricted stock units granted to the reporting person under the BKV Corporation 2024 Equity and Incentive Compensation Plan that vest in three equal annual installments beginning on March 10, 2027. Each restricted stock unit represents a contingent right to receive one share of common stock, par value $0.01 per share.

Represents restricted stock units granted to the reporting person under the BKV Corporation 2024 Equity and Incentive Compensation Plan that vest in three equal annual installments beginning on March 10, 2027. Each restricted stock unit represents a contingent right to receive one share of common stock, par value $0.01 per share.

Represents restricted stock units granted to the reporting person under the BKV Corporation 2024 Equity and Incentive Compensation Plan that vest in three equal annual installments beginning on March 10, 2027. Each restricted stock unit represents a contingent right to receive one share of common stock, par value $0.01 per share.

Represents restricted stock units granted to the reporting person under the BKV Corporation 2024 Equity and Incentive Compensation Plan that vest in three equal annual installments beginning on March 10, 2027. Each restricted stock unit represents a contingent right to receive one share of common stock, par value $0.01 per share.

Represents restricted stock units granted to the reporting person under the BKV Corporation 2024 Equity and Incentive Compensation Plan that vest in three equal annual installments beginning on March 10, 2027. Each restricted stock unit represents a contingent right to receive one share of common stock, par value $0.01 per share.

Represents restricted stock units granted to the reporting person under the BKV Corporation 2024 Equity and Incentive Compensation Plan that vest in three equal annual installments beginning on March 10, 2027. Each restricted stock unit represents a contingent right to receive one share of common stock, par value $0.01 per share.

Represents restricted stock units granted to the reporting person under the BKV Corporation 2024 Equity and Incentive Compensation Plan that vest in three equal annual installments beginning on March 10, 2027. Each restricted stock unit represents a contingent right to receive one share of common stock, par value $0.01 per share.

Represents shares of common stock, par value $0.01 per share ("Common Stock"), withheld to satisfy tax withholding obligations upon the vesting of restricted stock units previously reported on Form 4. This net settlement was approved by the board of directors of the Issuer pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended.

Represents shares of common stock, par value $0.01 per share ("Common Stock"), withheld to satisfy tax withholding obligations upon the vesting of restricted stock units previously reported on Form 4. This net settlement was approved by the board of directors of the Issuer pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended.

Represents shares of common stock, par value $0.01 per share ("Common Stock"), withheld to satisfy tax withholding obligations upon the vesting of restricted stock units previously reported on Form 4. This net settlement was approved by the board of directors of the Issuer pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended.

Represents shares of common stock, par value $0.01 per share ("Common Stock"), withheld to satisfy tax withholding obligations upon the vesting of restricted stock units previously reported on Form 4. This net settlement was approved by the board of directors of the Issuer pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended.

Represents shares of common stock, par value $0.01 per share ("Common Stock"), withheld to satisfy tax withholding obligations upon the vesting of restricted stock units previously reported on Form 4. This net settlement was approved by the board of directors of the Issuer pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended.

Represents shares of common stock, par value $0.01 per share ("Common Stock"), withheld to satisfy tax withholding obligations upon the vesting of restricted stock units previously reported on Form 4. This net settlement was approved by the board of directors of the Issuer pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended.

Represents shares of common stock, par value $0.01 per share ("Common Stock"), withheld to satisfy tax withholding obligations upon the vesting of restricted stock units previously reported on Form 4. This net settlement was approved by the board of directors of the Issuer pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended.

Represents shares of common stock, par value $0.01 per share ("Common Stock"), withheld to satisfy tax withholding obligations upon the vesting of restricted stock units previously reported on Form 4. This net settlement was approved by the board of directors of the Issuer pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended.

Represents shares of common stock, par value $0.01 per share ("Common Stock"), issued to Banpu Power US Corporation ("BPPUS") as 50% of the closing consideration pursuant to that certain Membership Interest Purchase Agreement, dated as of October 29, 2025 (the "Purchase Agreement"), by and between BPPUS and BKV Corporation (the "Issuer"), in exchange for one-half of the limited liability company interests in BKV-BPP Power LLC held by BPPUS prior to the closing of the transactions contemplated by the Purchase Agreement. The number of shares of Common Stock issued to BPPUS was determined by dividing the amount equal to 50% of the purchase price under the Purchase Agreement by $21.6609, the volume-weighted average price of the Common Stock during the twenty (20) consecutive trading-day period ended October 28, 2025.

BPPUS is a wholly owned subsidiary of Banpu Power Public Company Limited ("BPP"), which is a controlled subsidiary of Banpu Public Company Limited ("BPCL"). These shares are owned directly by BPPUS and indirectly by BPP and BPCL.

The shares were acquired under the BKV Corporation Employee Stock Purchase Plan ("ESPP") in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). The reporting person is voluntarily reporting this transaction.

In accordance with the ESPP, these shares were purchased at a price equal to 85% of the lesser of (i) closing price of the Issuer's common stock on the first trading day of the offering period, July 1, 2025, or (ii) closing price of the Issuer's common stock on the last trading day of the offering period, December 31, 2025.

The shares were acquired under the BKV Corporation Employee Stock Purchase Plan ("ESPP") in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). The reporting person is voluntarily reporting this transaction.

In accordance with the ESPP, these shares were purchased at a price equal to 85% of the lesser of (i) closing price of the Issuer's common stock on the first trading day of the offering period, July 1, 2025, or (ii) closing price of the Issuer's common stock on the last trading day of the offering period, December 31, 2025.

The shares were acquired under the BKV Corporation Employee Stock Purchase Plan ("ESPP") in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). The reporting person is voluntarily reporting this transaction.

In accordance with the ESPP, these shares were purchased at a price equal to 85% of the lesser of (i) closing price of the Issuer's common stock on the first trading day of the offering period, July 1, 2025, or (ii) closing price of the Issuer's common stock on the last trading day of the offering period, December 31, 2025.

The shares were acquired under the BKV Corporation Employee Stock Purchase Plan ("ESPP") in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). The reporting person is voluntarily reporting this transaction.

In accordance with the ESPP, these shares were purchased at a price equal to 85% of the lesser of (i) closing price of the Issuer's common stock on the first trading day of the offering period, July 1, 2025, or (ii) closing price of the Issuer's common stock on the last trading day of the offering period, December 31, 2025.

Represents shares of common stock, par value $0.01 per share ("Common Stock"), withheld to satisfy tax withholding obligations upon the vesting of restricted stock units previously reported on Form 4. This net settlement was approved by the board of directors of the Issuer pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended.

Represents shares of common stock, par value $0.01 per share ("Common Stock"), withheld to satisfy tax withholding obligations upon the vesting of restricted stock units previously reported on Form 4. This net settlement was approved by the board of directors of the Issuer pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended.

Represents shares of common stock, par value $0.01 per share ("Common Stock"), withheld to satisfy tax withholding obligations upon the vesting of restricted stock units previously reported on Form 4. This net settlement was approved by the board of directors of the Issuer pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended.

Represents shares of common stock, par value $0.01 per share ("Common Stock"), withheld to satisfy tax withholding obligations upon the vesting of restricted stock units previously reported on Form 4. This net settlement was approved by the board of directors of the Issuer pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended.

Represents shares of common stock, par value $0.01 per share ("Common Stock"), withheld to satisfy tax withholding obligations upon the vesting of restricted stock units previously reported on Form 4. This net settlement was approved by the board of directors of the Issuer pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended.